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Lead (Pb), cadmium (Cd) and aluminum (Al) were determined in 437 individual samples of infant formulae, oral
electrolytes and 5% glucose solutions available in Canada. In the electrolytes, Cd and Pb concentrations were all
below 0.01 and 0.041ngg
 1, respectively. In the 5% glucose solutions, Pb and Cd levels averaged 0.01 and
0.09ngg
 1, respectively. Reported on an as-consumed basis, Pb levels in milk- and soya-based formulae averaged
0.90 and 1.45ngg
 1, respectively, while Cd levels averaged 0.23 and 1.18ngg
 1, respectively Average Al levels on
an as-consumed basis were 440ngg
 1 (range 10–3400ngg
 1) in milk-based formulae and 730ngg
 1 (range
230–1100ngg
 1) in soy-based formulae. Al concentrations increased in the following order: plain
formula5low-iron formula5iron-supplemented formula5casein hydrolysate formula premature
formula soy formula. For example, in the powdered formulae, average Al concentrations were 18ngg
 1 for
plain milk-based, 37ngg
 1 for low-iron, 128ngg
 1 for iron supplemented, 462ngg
 1 for lactose-free, 518ngg
 1
for hypoallergenic and 619ngg
 1 for soy-based formula. Al concentrations, as-consumed, increased with
decreasing levels of concentration: powder5concentrated liquid5ready-to-use. Formulae stored in glass bottles
contained between 100 and 300ngg
 1 more Al than the same formulae stored in cans. The source of the increased
Al did not appear to be the glass itself, because most electrolytes and glucose solutions, also stored in glass,
contained less than 8ngg
 1 Al. Corresponding differences in Pb and Cd levels were not observed.
Al concentrations varied substantially among manufacturers; however, all manufacturers were able to produce
plain milk-based formulae containing less than 50ngg
 1 Al, i.e. within the range of Al concentrations found in
human milk. Next to soya-based and hypoallergenic formulae, premature formulae contained among the highest
concentrations of Al, ranging 851–909ngg
 1 from one manufacturer and 365–461ngg
 1 from another.
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Introduction
Infants are particularly sensitive to the effects of
ingested toxicants as food consumption is greater on
a body-weight basis. Gastrointestinal absorption of
most chemicals is substantially elevated prior to
weaning and many organs, such as kidneys, are
underdeveloped, while the physical development of
critical organs impacting on the health of the
infant throughout life is accelerated (Oskarsson et al.
1998). Infant formulae, often a single brand, may
constitute a sole-source food for several months of an
infant’s life.
Lead is a potent neurotoxin for which no safety
threshold has yet been found (US Environmental
Protection Agency 2003). Exposure to Pb in utero
and during infancy irreversibly affects development of
the nervous system, causing reduced IQ and learning
disabilities. Cd has estrogenic properties and causes an
increased incidence of cancer in mice (Johnson et al.
2003). Chronic exposure to Cd and Pb is associated
with kidney damage in adults (Navas-Acien et al.
2009). Infants, particularly those born prematurely,
have reduced renal function and their developing
kidneys are more susceptible to damage caused by
excessive Cd and Pb in their diet. Al is a potent
neurotoxin; long-term feeding of Al-containing total
parenteral solutions to preterm infants caused
impaired mental development at 18 months
(Committee on Nutrition 1996; Klein et al. 2004).
Also, excess Al in the blood is selectively incorporated
into the bones of infants, resulting in a weakened bone
structure (Bernardo et al. 2010). Al can only be
removed from blood via the kidneys, and severe renal
disorders can result in accumulation of Al in the blood,
a situation potentially exacerbated by the action of
higher levels of Cd and Pb on the kidneys. Finally,
nothing is known about potential synergism between
Al and Pb neurotoxicity. Thus, the monitoring of these
elements in infant formulae is a high priority, interna-
tionally (Riolfatti and Veronese 1990; Baxter et al.
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1999; MAFF UK 1999; Rodriguez Rodriguez 1999;
Tripathi et al. 1999; Ikem et al. 2002; Navarro-Blasco
and Alvarez-Galindo 2003; Ursinyova and
Masanova 2005; Hafez and Kishk 2008; US FDA
2008; Wojciechowska-Mazurek et al. 2008;
Winiarska-Mieczan 2009; Al Khalifa and Ahmad
2010; Burrell and Exley 2010).
To optimize infant development, ingredient
requirements for infant formulae are regulated and
are sometimes country-specific. As a result, country-
to-country variations in the concentrations of contam-
inants are to be expected. Previous studies have shown
that typical Pb concentrations in all types of infant
formula are in the order of 1–10ngg
 1 as-consumed
(Dabeka 1989; Tripathy et al. 1999; Ikem et al. 2002),
although levels as high as 143ngml
 1 (Hafez and
Kishk 2008) and 450ngg
 1 (Winiarska-Mieczan 2009)
have been reported.
Cadmium concentrations, in addition to varying
with country (Ikem et al. 2002), are usually less than
1ngg
 1 for milk-based formulae and slightly over
1ngg
 1 for soy-based formulae (Dabeka 1989; Eklund
and Oskarsson 1999; Rodriguez et al. 1999; Ursinyova
and Masanova 2005; Wojciechowska-Mazurek et al.
2008). Cd levels as high as 15ngg
 1 have been reported
for soy formula in the UK (MAFF UK 1999).
Aluminum concentrations are known to vary
widely, from an average of 58ngg
 1 in formulae
from Nigeria (Ikem et al. 2002) up to 5600ngg
 1 for a
soy-based formula in the UK (MAFF UK 1999). Also,
in Canada, soy-based formulae consistently contained
higher Al concentrations than milk-based formulae
(Dabeka and McKenzie 1990).
The purpose of this survey was to establish whether
the concentrations of Pb, Cd and Al in infant formulae
sold in Canada have changed since previous surveys
(Dabeka 1989; Dabeka and McKenzie 1990). The
ultimate goal was to ensure that concentrations of
trace elements in infant formulae are equivalent to or
lower than those found in human milk. Electrolytes
and 5% glucose solutions were also analysed because
these are often fed to infants with diarrhoeal
dehydration.
Experimental
Samples
Infant formulae, electrolytes and 5% glucose solutions
were obtained by the Canadian Food Inspection
Agency from retail stores, medical centres and hospi-
tals between January 1999 and May 1999. An attempt
was made to obtain three different lots of each
product. Samples (n¼243) were stored at room
temperature until analysed. Analyses were performed
in the Quebec Regional Laboratory of the Health
Products and Food Branch of Health Canada.
Reagents
Demineralized water was used wherever water is
specified. Baker Ultrex-grade high-purity nitric and
perchloric acids were used for digestions.
Reagent-grade acids were used for washing flasks.
Certified standard solutions of the elements traceable
to the US National Institute of Standards and
Technology were purchased from SCP Science
(Montreal, Quebec, Canada). Other chemicals were
reagent-grade.
Contamination control
Special contamination control measures were required
to accurately quantify the background concentrations
of Pb, Cd and Al in the reagent blanks in the absence
of a clean room.
New glassware was soaked in 5% Decon detergent
solution, rinsed with water, soaked in 5% nitric acid
solution and again rinsed with water. Quartz
Erlenmeyer digestion flasks were cleaned by boiling
concentrated nitric acid in them until interior side and
rim were wetted. The outer rim mouth of the flask was
immersed in warm concentrated nitric acid. This step
was critical in reducing contamination from residues
on the outer rim of the flask when solution was poured
from the flask. Used vessels were washed as above
without soaking in Decon. Flasks were stored in dilute
nitric acid solution and rinsed directly with deionized
water just prior to use.
Polyethylene gloves were washed with liquid deter-
gent and worn at all times when handling flasks and
utensils. Body movements over open vessels were
avoided to prevent dust or particulate contamination.
When not in use, vessels were covered with plastic film
(Saran Wrap
TM). The exterior of all vessels, including
reagent bottles, was kept clean by rinsing with water
and wiping dry with lint-free cellulose wipes (Kimberly
Clark Kimwipes). Teflon-FEP acid bottles were used
to store high purity acids, and were stored in polyeth-
ylene bags. Except for fume-hood digestions, most
sample manipulations were made under a clean air
canopy.
During initial analyses, several problems were
encountered with Pb and Cd contamination.
A Brinkman plunger-type acid dispenser was found
to be a source of Pb contamination, with the first 25-ml
portion of pumped acid containing 0.15ngml
 1
Pb while subsequent portions yielded acid with less
Food Additives and Contaminants 745than 0.025ngml
 1. Thus, acids were dispensed using
a graduated cylinder instead of an acid dispenser.
Al method
Samples (as sold) (20g electrolyte, 20g ready-to-use,
10g concentrated liquid or 3g powdered concentrate)
were digested with 25ml nitric acid and 20ml perchlo-
ric acid (Dabeka and McKenzie 1986), and the
solutions were diluted to about 80 ml with water.
Internal standard (1 ml 60ngml
 1 yttrium (Y)) was
added to a 5-ml sample aliquot.
Measurements were made on a VG-PlasmaQuad-2
(VG-Elemental, Winsford, UK) inductively coupled
plasma mass spectrometer (ICPMS) fitted with a
Teflon V-groove nebulizer and Gilson 222 autosam-
pler. Standard operating conditions were: argon (Ar)
99.998% purity; plasma power 1350 W; spray chamber
temperature 5 C. Ar gas flows were: coolant
13.5lmin
 1, auxiliary 1.1 lmin
 1 and nebulizer 0.860
lmin
 1. Solution uptake rate was 1mlmin
 1. The
ICPMS was operated in scanning mode (30 sweeps,
500ms) with one 57-s integration measurement for each
solution. Isotopic measurements were made on
27Al
using
89Y as internal standard.
Fifteen batches were run. Each consisted of 10
standards (0, 1, 2, 5, 10, 25, 50, 100, 200, 400ngml
 1),
seven reagent blanks, one or two reagent blank spikes,
two unspiked sample replicates, two spiked sample
replicates and about 20 samples, each analysed in
duplicate, per batch. The spike added was 10,000ng
(500ngg
 1 for 20g ready-to-use formula) for both the
blank and sample spikes.
Pb and Cd determinations
Samples (20g electrolyte, 20g ready-to-use, 10g con-
centrated liquid, or 3g powdered formula) were
digested with nitric and perchloric acids, and Pb and
Cd were coprecipitated with ammonium pyrrolidine
dithiocarbamate according to the method of Dabeka
and McKenzie (1986). The precipitate was dissolved
(16 h) off the filter using 1ml of 25 % HNO3, then
0.5ml internal standard containing 20ngml
 1 each of
indium (In) and rhenium (Re) were added, followed by
3.5ml water. Cd and Pb were measured by ICPMS
using the instrument and conditions described above
for Al, except that the ICPMS was operated in peak
jumping mode (175 sweeps, 3 channel per mass, 0.02
amu spacing, 15,000ms dwell time) with one 57-s
integration measurement for each solution. Isotopic
measurements were made on
111Cd and
208Pb using
115In and
185Re as internal standards. No isobaric
interference correction algorithm was applied.
The samples were run in 16 analytical batches.
Each analytical batch consisted of 10 standards
(0, 0.05, 0.1, 0.25, 0.5, 1.0, 2.0, 5.0, 10 and
20ngml
 1, seven reagent blanks, one or two reagent
blank spikes, two unspiked sample replicates, two
spiked sample replicates, duplicates of a milk powder
SRM (NIST 1545) and duplicates of about 20 samples.
Reporting results
Reported levels are based on an as-consumed basis
for the ready-to-use, concentrated liquid and powder
formulas. Label instructions were used to convert the
concentrated liquid and powdered formulae concen-
trations to an as-consumed basis. All results less than
the limit of detection (LOD) were reported as numeric
value of the LOD.
Statistical comparisons
SigmaStat Version 3.11 for Windows was used for
statistical calculations. The data were first checked for
normality, then differences between selected groups
were tested using a multiple t-test.
Results and discussion
Quality control results
For aluminum determinations, blank spike recoveries
averaged 95% (range 81–109%). Sample spike recov-
eries averaged 98% (range 71–156%). The average
limit of detection, defined as three times the standard
deviation of the 7 reagent blanks in each batch divided
by the sample weight, was 3.5ngg
 1 (range 1–
11ngg
 1).
For lead and cadmium measurements, blank spike
recoveries averaged 95% (range 86–103%) for Pb, and
85% (range 77–94%) for Cd. Sample spike recoveries
averaged 97% (range 87–109%) for Pb and 88%
(range 78–98%) for Cd. Pb levels in the SRM (mean
16ngg
 1, range 14–19ngg
 1) were slightly less than
the certified level of 19 3ngg
 1. Cd levels in the
SRM (mean 0.45ngg
 1, range 0.13–0.77ngg
 1) were
much less precise, but the average agreed with the
certified level of 0.5 0.25ngg
 1.
Element concentration results
Table 1 summarizes the concentrations of the elements
found in each oral electrolyte, glucose solution and
infant formula by type.
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In the electrolytes, Cd and Pb concentrations were
all below 0.01 and 0.41ngg
 1, averaging 0.01 and
0.16ngg
 1, respectively (Table 1). In the 5% glucose
solutions, Pb and Cd levels averaged 0.01 and
0.09ngg
 1, respectively.
For the infant formulae, lower Pb, Cd, and Al
concentrations were observed relative to results
obtained in an earlier survey (Dabeka 1989; Dabeka
and McKenzie 1990) (Table 2). The average 1989 Pb
level of 1.58ngg
 1 (range 0.36–6.08ngg
 1) in both
milk and soya ready-to-use formulae decreased to
1.45ngg
 1 for ready-to-use soya-based formulae and
to 0.90ngg
 1 for ready-to-use milk-based formulae.
Average Cd levels decreased from 0.35 to 0.23ngg
 1 in
ready-to-use milk-based formulae and from 3.39 to
1.18ngg
 1 in soya-based formulae.
Average levels of Pb and Cd were generally lower
than or comparable to levels reported in the literature.
Pb in milk-based formulae in Italy were found to vary
from54ngml
 1 for mature formula to 95ngml
 1 for
premature formula (Riolfatti and Veronese 1990). In
the same study, average Cd concentrations varied from
0.06ngml
 1 for milk-based adapted formula to
1.31ngml
 1 for hypoallergenic formula. In the UK,
powdered formulae contained between51and3ngg
 1
(milk-based) and 14ngg
 1 Cd (soy-based, n¼1), and
510–20ngg
 1 Pb. Ready-to-use milk-based formulae
contained 51 to 1ngg
 1 Pb, and 50.1ngg
 1 to
2.9ngg
 1 Cd (MAFF UK 1999). In India, geometric
mean trace element concentrations varied by milk type,
ranging 1.7–3.35ngg
 1 for Pb and 0.07–0.10ngg
 1 for
Cd (Tripathi et al. 1999). Powdered milk formula in
Saudi Arabia contained 18ngg
 1 Pb and 7ngg
 1 Cd
(Al Khalifa and Ahmad 2010). In Spain, average levels
of Pb and Cd in reconstituted powdered formulae were
11.5 and 6.8ngg
 1, respectively (Rodriguez Rodriguez
1999). Cd concentrations in formulae sold in Poland
varied with formula type from 0.4 to 2ngg
 1, consis-
tent with levels found in Canada. Pb concentrations in
Polish formulae were considerably higher (Winiarska-
Mieczan 2009), averaging 198–450ngg
 1, over 100
times higher than those found in this study. Another
Polish study found a higher average concentration of
Cd (4ngg
 1), but a lower concentration of Pb
(31ngg
 1) (Wojciechowska-Mazurek et al. 2004). In
the Slovak Republic, formulae contained 0.4ngg
 1 Cd
and 5ngg
 1 Pb (Ursinyova and Masanova 2005).
Similar mean concentrations of 0.67ngg
 1 Cd and
5.94ngg
 1 Pb were found in formulae from the Czech
Republic (Ursinyova and Hladikova 1997). A com-
parison of formulae from Nigeria, UK and USA found
very low levels of both Pb and Cd. Average
Pb concentrations varied from ‘‘not detected’’ in US
formula to 0.8ngg
 1 in UK formula, while Cd varied
from ‘‘not detected’’ in Nigerian and US formula to
0.3ngg
 1 in UK formula (Ikem et al. 2002). In
Swedish formulae, average Cd concentrations ranged
1.1–22ngg
 1 depending on formula type (Eklund and
Oskarsson 1999). While sample-type variations were
also found in this study, the levels and concentration
differences were substantially lower. For example,
among the powdered formulae in this study, mean
Cd levels ranged from 0.04ngg
 1 for plain milk-based
formula to 0.48ngg
 1 for lactose-free, 0.53ngg
 1 for
hypoallergenic, 0.84ngg
 1 for whey and 1.56ngg
 1
for soya-based formula (Table 1). In Australia, the
geometric mean Pb concentration in infant formulae
was 1.6ngg
 1 (range 0.07–11.4ngg
 1) (Gulson et al.
2001). In Taiwan, Pb and Cd averaged 8 and 5ngg
 1,
respectively (Ding 2008). Nineteen samples of ‘‘since
birth’’ formula powders sold in Saudi Arabia con-
tained means of 18ngg
 1 Pb and 7ngg
 1 Cd
(Al Khalifa and Ahmad 2010).
In Canadian human milk sampled in 1981, average
levels of Pb and Cd were about 1.04 and 0.08ngg
 1,
respectively (Dabeka et al. 1986). Thus, levels of Pb in
milk-based formulae are, on average, marginally
lower than levels found previously in human milk,
while Cd levels are slightly higher. The concentrations
of lead in the formulae are all well below the
Table 2. Comparison of current Al, Pb and Cd levels in ready-to-use formula with previous Canadian surveys.
Al,ngg
 1, mean (range) Pb,ngg
 1, mean (range) Cd,ngg
 1, mean (range)
1990
a This study 1989
b This study 1989
b This study
Milk-based 130 440 1.58
c 0.90 0.35 0.23
(10–360) (10–3400) (0.36–6.08) (0.14–2.46) (0.032–3.4) (0.03–1.26)
Soya-based 1980 730 1.45 3.39 1.18
(400–6400) (230–1100) (1.1–2.1) (3.12–14.8) (0.71–2.95)
Notes:
aDabeka and McKenzie (1990).
bDabeka (1989).
cPb values for 1989 survey include both milk- and soya-based formulae.
748 R. Dabeka et al.regulatory limits of 80ngg
 1 for ready-to-serve for-
mula and 150ngg
 1 for concentrated liquid formula
(Department of Justice 2011) in Canada, 20ngg
 1 for
ready-to-serve formula in Europe (Commission of the
European Communities 2001).
Aluminum
Aluminum levels in 26% of the electrolyte and glucose
solutions were less than 8ngg
 1 (Table 1). Among the
electrolytes sampled (various brands from three man-
ufacturers), the highest concentrations of Al were
found in a brand that has since been discontinued
(263ngg
 1 in unflavoured, and 283ngg
 1 in the
flavoured version of the same discontinued brand).
Of seven brands of electrolytes from a second manu-
facturer, four contained 55ngg
 1 Al, while three
contained 97, 98 and 119ngg
 1 Al. In the case of
5% glucose solutions, two samples from one manu-
facturer contained 175 and 239ngg
 1 Al, while the
samples from two other companies contained
56ngg
 1 Al. Considering that electrolytes can be
given to premature infants as well as to infants
who are ill, Al concentrations should be kept as low
as possible. The results indicate that manufacturers
are, with careful manufacturing practices, capable of
producing electrolyte and glucose solutions with Al
concentrations below 10ngg
 1.
In concentrated liquid milk-based infant formulae,
average Al levels were 131ngg
 1, and, by formula
type, were 33ngg
 1 for plain, 37ngg
 1 for low-iron,
90ngg
 1 for iron-supplemented, and 467ngg
 1 for
lactose-free formulae (Table 1). Soya-based concen-
trated liquid formulae contained substantially higher
Al concentrations (average 706ngg
 1) than milk-based
formulae (average 131ngg
 1). Iron-supplemented
concentrated liquid soy-based formulae contained an
average of 757ngg
 1 Al, slightly higher than the
non-supplemented formulae (688ngg
 1).
The average Al concentration in all the milk-based
powdered formulae was 177ngg
 1. Levels varied by
formula type from 18ngg
 1 for plain formulae to
462ngg
 1 for lactose-free, and 518ngg
 1 for hypoal-
lergenic (Table 1). Two powdered whey-based formu-
lae contained a mean of 39ngg
 1 on an as-consumed
basis. Al concentrations in an amino-acid modified
formula and a protein-free formula were 774 and
542ngg
 1, respectively. Soya-based powdered formu-
lae contained an average of 733ngg
 1, with the plain
formulae containing less Al (619ngg
 1) than those
fortified with iron (905ngg
 1).
There are large variations of Al concentrations
reported for infant formula from other countries.
A comparison of levels (as consumed) in powdered
formula found average concentrations of 58ngg
 1 in
Nigerian formulae, 92 and 101ngg
 1 in UK, and, in
the US, 150 and 460ngg
 1 in milk- and soy-based
formula, respectively (Ikem et al. 2002). Powdered
formula imported from Europe into Turkey contained
1211–10,925ngg
 1 Al as-sold (Sahin et al. 1995). In
Saudi Arabia, ‘‘since birth’’ and follow-on powdered
formulae contained (as-sold) mean concentrations of
1944 and 1600ngg
 1, respectively (Al Khalifa and
Ahmad 2010). On a ready-to-use basis, powdered milk-
and soya-based formula in the UK in 1990 contained
40–200 and 640–1340ngg
 1, respectively (Baxter et al.
1990). A recent UK survey (Burrell and Exley 2010)
found different types of ready-to-use milk-based for-
mula contained average concentrations ranging from
175 to 700ngg
 1 Al. While the highest reported
concentration of 863ngg
 1 Al in the UK study
(Burrell and Exley 2010) was lower than the maximum
concentration of 3442ngg
 1 found in this study
(Table 1), the lowest concentration of 131ngg
 1 in
an organic formula was much higher than the 10ngg
 1
Al found in the present study. Average Al levels in the
other ready-to-use formulae were 730ngg
 1 for the
soya-based, 510ngg
 1 for the whey-based and
72ngg
 1 for a modified fat supplement (Table 1).
Al levels were generally higher in the milk-based
ready-to-use formulae (average 437ngg
 1) than in
either powdered (average 177ngg
 1) or concentrated
liquid (131ngg
 1) formulae, suggesting a contribution
of the manufacturing process to increased Al. For
plain milk-based formulae as-consumed, the Al con-
centration increased from the powder (18ngg
 1)t ot h e
concentrated liquid (mean 33ngg
 1) to the ready-to-
use (mean 379ngg
 1).
Al levels in the soya-based infant formulae
were substantially lower (mean 730ngg
 1, range
230–1100ngg
 1) than in our Canadian 1990 results
(Dabeka and McKenzie 1990) (mean 1980ngg
 1,
range 400–6400ngg
 1), and it is clear that efforts to
reduce Al levels in these products have been successful
(Table 2). The mean level of Al in soya-based formulae
in this study was slightly higher than that of
640ngml
 1 reported for Britain (Baxter et al. 1991),
and 573ngml
 1 (range 313–3479ngml
 1) reported for
Spain (Navarro-Blasco and Alvarez-Galindo 2003).
In the milk-based formulae, however, average levels in
this study were about three times higher than in 1990
(Table 2). This appeared to be partially due to the
introduction of many more complex formulae and, in
some cases, to what appears to be inadequate controls
over source materials or manufacturing processes. For
example, the highest concentration of Al (3400ngg
 1)
was found in a milk-based formula fortified with iron
rather than in a soya-based formula. Other milk-based
products from this manufacturer contained much
Food Additives and Contaminants 749lower concentrations of Al, as did all of the soya-based
products.
Improved manufacturing practices
As noted in the Introduction, the fundamental goal for
both manufacturers and health authorities is to ensure
that contaminant levels in infant formulae are lower
than or of the same order of magnitude as levels
present in human milk.
While this goal has been met with respect to Pb and
Cd in most of the milk-based formula products,
lot-to-lot variations in Pb and Cd concentrations of
the same product suggest that, with judicious control
over ingredients, concentrations of Pb and Cd in some
of the formula products can be reduced even further.
For example, of four lots of a brand of lactose-free
concentrated liquid formula from one company, one
contained 2.04ngg
 1 Cd, while the other three con-
tained 0.07–0.15ngg
 1. Of three lots of a lactose-free
powdered formula from another company, one con-
tained 3.5ngg
 1 Pb while the other two contained 2.4
and 0.8ngg
 1.
In the case of Al, while there were individual
products and lots with relatively high concentrations of
Al, there is sufficient evidence that, with adequate
controls, all manufacturers can lower Al concentra-
tions significantly. All manufacturers were able to
produce milk-based formulae which were very low in
Al. For milk-based formulae stored in cans, ready-to-
use formulae from one company consistently contained
low Al concentrations (11ngg
 1 Al). The same com-
pany produced six lots of concentrated liquid formula
containing 2–9ngg
 1 and three lots of powdered
formula contained 2–47ngg
 1 Al, as-consumed. Low
Al levels were found in powdered milk-based formula
products from two other manufacturers, with three lots
from each containing 9–18ngg
 1, and between 6 and
11ngg
 1. Thus, it should be possible for manufac-
turers to consistently produce milk-based infant for-
mulae containing less than 50ngg
 1 Al.
Al is an environmentally ubiquitous element and
one would generally expect some increase in Al
concentrations of formulae fortified with iron or
other ingredients. However, even with these more
complex formulae, manufacturers have demonstrated
the ability to control contamination. For example,
three lots of concentrated liquid formula fortified with
iron from one company contained 70–74ngg
 1. From
another company, both the concentrated liquid and
powdered formulae fortified with iron contained,
respectively, 15–28 and 7–25ngg
 1. Two lots of
powdered formula with added rice starch from a
third company contained 24 and 35ngg
 1 Al.
From the same company, three lots of each of two
different formulations of powdered formula fortified
with iron contained, respectively, 12–17 and
33–74ngg
 1 Al. Thus, with manufacturing controls
over the Al content of ingredients, the above data
indicate that it should be possible to consistently keep
Al concentrations in milk-based iron-fortified formu-
lae below 100ngg
 1.
Soya-based formulae usually contain higher con-
centrations of Al than milk-based formulae (Baxter
et al. 1990), but there is evidence that some manufac-
turers can lower concentrations of Al in soy-based
formulae even further. Table 3 indicates that, of three
manufacturers with ready-to-use, powdered and con-
centrated liquid soya-based infant formula, Company
A’s products consistently contained statistically lower
(p 0.003 for each of the concentrated forms) concen-
trations (mean 293ngg
 1, range 199–568ngg
 1)o fA l
than the other two companies: mean 772ngg
 1 (range
693–898ngg
 1) and mean 944ngg
 1 (range
730–1121ngg
 1). In addition, the Al concentration in
Company B’s powdered soy formula was significantly
(p¼0.036) less than Company A’s soy formula
powder. Two formulations (regular and follow-up) of
one brand of soya-based powdered formulae from
Company D also contained higher Al concentrations
than Company C’s products, averaging over three lots
each, 658 and 1152ngg
 1, respectively. The same
brand of the regular formulation (as opposed to
follow-up), but sold as a concentrated liquid formula,
contained 757ngg
 1, as-consumed. Thus, for the same
formula types, there is greater variation in Al concen-
trations among companies than among lots within
each company. Based on a comparison of results from
company to company, it appears that, by controlling
the ingredients used in preparation of their soya-based
formulae, Al concentrations in many of these could be
reduced by at least 50%. Soya-based formulae are not
Table 3. Variation in Al levels in plain soya-based infant
formulae by manufacturer.
Manufacturer
a Type n
Mean
(ngg
 1)
SD
(ngg
 1)
Company B Ready-to-use 4 781 57
Company A 6 939 153
Company C 4 367
a 156
Company B Concentrated liquid 3 831 59
Company A 3 956 102
Company C 3 279
a 16
Company B Powdered 3 702
b 75
Company A 3 945 113
Company C 3 209
a 16
Notes:
aStatistically lower (p 0.003) than either Company
B’s or Company A’s product of the same type.
bStatistically lower (p¼0.036) than Company A’s powdered
soya formula.
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Food Additives and Contaminants 751recommended for feeding to preterm infants
(Committee on Nutrition 1998) or to infants with
milk allergies (Canadian Paediatric Society, Dietitians
of Canada and Health Canada 2005); thus, the risks
associated with the higher Al concentrations in these
formulae are minimal.
In general, additional processing is required to
produce lactose-free and hypoallergenic formulae, and
Al concentrations in these formulae can be expected to
be somewhat higher than in regular milk-based for-
mulae. However, similar to soya-based formulae, there
are substantial differences among manufacturers in
terms of ability to control Al concentrations in these
specialty formulae. For example, for concentrated
liquid lactose-free formula, three lots of Company
A’s product contained 136–149ngg
 1 Al, whereas four
lots of Company B’s lactose-free product contained
643–796ngg
 1, 4–5-fold more. Similarly, for
ready-to-use casein hydrolysate formula stored
in cans, three lots of Company B’s product contained
458–572ngg
 1 Al, whereas three lots of Company A’s
product contained significantly more: 801–984ngg
 1.
It was reported that consumption of protein hydroly-
sate formula containing 773ngml
 1 (95% CI
632–914ngml
 1) compared with human milk contain-
ing 9.2ngml
 1 (95% CI 5.6–12.7ngml
 1) resulted in
a statistically significant (p¼0.028) increase in plasma
Al concentrations for infants with normal kidney
function (Hawkins et al. 1994). While no correspond-
ing health effects associated with this increase have
been found, additional steps to reduce the levels of Al
in these products would be prudent.
As reported for a previous Canadian survey
(Gruskin 1991), formula stored in glass bottles had
higher concentrations of Al than the same formula
stored in metal cans (Table 4). On average, the glass
bottled formulae contained 100–300ngg
 1 more Al
than the same formulae stored in cans. Thus, it can be
surmised that additional Al is entering the formula at
one or more of the following points: glass containers
used for storing formula (washing, leaching), the lids
(leaching), and/or equipment and processes used for
filling the glass containers. Al contamination of glass-
stored formulae appears common to more than one
manufacturer, but the magnitude of the contamination
is product-dependent in some cases. The low concen-
trations of Al in most of the glass-stored electrolyte
and glucose solutions suggest that elimination of the
contamination source is technologically possible.
Infants born prematurely generally have weakened
kidney function, and premature formula given to these
infants should have as low concentrations of Al as
technologically feasible using good manufacturing
practices, i.e. substantially less than 100ngg
 1. Three
different formulations (one sample each) of Company
B’s premature formula, all sold under the same brand
name (not tabulated), contained, respectively, 851, 955
and 909ngg
 1 Al. These are among the highest
concentrations found for any of the milk-based
formulae and are substantially higher than two pre-
mature formulations, sold under the same brand name
by Company D: a single sample of the first formulation
contained 365ngg
 1 Al, while three lots of the second
formulation contained 449–461ngg
 1 Al. The above
formulae are all stored in glass and it may be possible
to lower a portion of the Al present in them by finding
and eliminating the Al contamination source(s) related
to storage in glass (Table 4). Based on the differences in
Al concentrations between the tested premature for-
mulae manufactured by Company D and those
premature formulae manufactured by Company B,
screening of ingredients and processes for Al contam-
ination may also lower the Al content.
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